| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-16 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-14 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |